Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 12, 2025 (GLOBE ...
Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a significant decline in short interest in ...
NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the Video Experience Cloud, today announced that it will ...
Additionally, ART12.11, our innovative CBD-TMP cocrystal, is well positioned to begin clinical trials this year. Targeting ...
Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Nab., Saint Petersburg 199034, Russian Federation ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Overview: Cocrystal Pharma, Inc. is a biotechnology company dedicated to discovering and developing antiviral therapeutic treatments for serious and chronic viral diseases, with a market cap of $ ...
(The term “cocrystal” refers to having two or more molecular compounds in a single lattice. A cocrystal structure results from any observation of a ligand bound within a biomolecule, such as an enzyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback